Open for bids Tender Czech Republic ICB TOT Ref. 152449085

Parenteral Cytostatic Drug with the Active Tender - 152449085

Tender notice from Czech Republic, published on 13 Nov 2026.

Executive Summary

Title/Summary: Tender for the supply of parenteral cytostatics containing the active substance Ifosfamide issued by Fakultní nemocnice Ostrava, Czech Republic. The estimated value is approximately 6,288,884.32 CZK. Submission deadline is December 15, 2026.

Scope Of Work: The contract involves the continuous and repeated supply of the medicinal product 'Parenteral cytostatic with the active substance Ifosfamide' in the form of a powder for preparing an infusion solution, available in strengths of 1 g and 2 g per vial. The supplies must comply with the specifications outlined in the tender documents and their appendices.

Qualification Criterion: Bidders must meet specific eligibility criteria as detailed in the tender documents. This includes relevant experience in supplying similar medicinal products, adherence to technical requirements, and submission of mandatory documents such as certifications and registrations. Compliance with local regulations and standards applicable to pharmaceutical supplies is also required.

Key facts

Summary
Parenteral Cytostatic Drug with the Active Substance Ifosfamide
TOT Ref. No.
152449085
Document Ref. No.
Login to see
Country
Czech Republic
Notice type
Tender
Competition
ICB
Publication date
13 Nov 2026
Bid deadline
15 Dec 2026
EMD
Refer Document
Tender value
CZK 6288884.32
Purchaser ownership
Public
Financier
Self Financed

CPV classification

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

Tender details are for registered users

Login to see details

Documents

Tender Notice
Login to view

Similar tenders

Tender Country TOT Ref. No. Bid deadline
Medicinal Product of Atc Group L04ac24 with the Active Substance Mirikizumab Czech Republic 152647180 18 Dec 2026
Medicinal Product of Atc Group L03ab13 with the Active Ingredient Peginterferon Beta-1A Czech Republic 152644383 18 Dec 2026
Medicinal Product of Atc Group R03dx10 with the Active Substance Benralizumab Czech Republic 152641430 18 Dec 2026
Medicinal Product of Atc Group S01ba01 with the Active Substance Dexamethason Czech Republic 152641319 18 Dec 2026
Accessories for Pipettes Czech Republic 152607428 23 Nov 2026

Czech Republic Public Procurement Intelligence

Frequently asked questions

The last date to submit a bid for Parenteral Cytostatic Drug with the Active Substance Ifosfamide is 15 Dec 2026. Submit before this date to be considered.

This tender has been issued by OSTRAVA UNIVERSITY HOSPITAL in Czech Republic.

The estimated tender value is CZK 6288884.32. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender is classified under the following CPV code(s): 33652100 - Antineoplastic agents.

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 152449085. The purchaser document reference is available after login.

See the Similar Tenders section on this page or browse other tenders from Czech Republic.

This tender falls under Materials and Products, Technology and Equipment in Czech Republic. Suppliers in these sectors can track similar Czech Republic tenders using CPV-based alerts.